Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EXE vs GSK✓SelectedUSD · GSKEXE vs GSK performance historyLatest closeAs of-1.42%11/20
Stock and ETF performance explorer

EXE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+132.7%
GSK return
+72.2%
Excess return
+60.5%
Maximum drawdown
-32.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%-0.1%-1.3%-1.4%
7D-8.2%-5.3%-2.9%-7.7%
30D-11.9%-3.7%-8.2%-11.6%
3M-14.9%-7.3%-7.6%-14.2%
6M-16.8%-4.2%-12.5%-16.5%
YTD-24.6%+0.9%-25.4%-25.1%
1Y-27.3%+7.3%-34.6%-28.3%
3Y+8.1%+52.7%-44.6%-0.6%
5Y+67.3%+40.1%+27.2%+58.2%
All+132.7%+72.2%+60.5%+103.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling